REQUEST A DEMO
Total
USD $0.00
Search more companies

Iberfarma S.A. Iberoamericana de Farmacos y Quimicos (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Iberfarma S.A. Iberoamericana de Farmacos y Quimicos Profile Updated: February 07, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Iberfarma S.A. Iberoamericana de Farmacos y Quimicos is based in Ecuador. The head office is in Quito. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on August 11, 2003. Iberfarma S.A. Iberoamericana de Farmacos y Quimicos currently employs 6 (2024) people. From the latest financial highlights, Iberfarma S.A. Iberoamericana de Farmacos y Quimicos reported a net sales revenue increase of 657.17% in 2024. There was a total negative growth of 82.99% in Iberfarma S.A. Iberoamericana de Farmacos y Quimicos’s total assets over the same period. The enterprise’s net profit margin decreased by 6.19% in 2024.

Headquarters
Catalina Aldaz N34-168, Edificio Recoleta Bldg. , Floor 75
Quito; Pichincha;

Contact Details: Purchase the Iberfarma S.A. Iberoamericana de Farmacos y Quimicos report to view the information.

Basic Information
Total Employees:
Purchase the Iberfarma S.A. Iberoamericana de Farmacos y Quimicos report to view the information.
Registered Capital:
Purchase the Iberfarma S.A. Iberoamericana de Farmacos y Quimicos report to view the information.
Financial Auditors:
Purchase the Iberfarma S.A. Iberoamericana de Farmacos y Quimicos report to view the information.
Incorporation Date:
August 11, 2003
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
70%
Purchase this report to view the information.
20%
Purchase this report to view the information.
5%
Purchase this report to view the information.
5%
Company Performance
Financial values in the chart are available after Iberfarma S.A. Iberoamericana de Farmacos y Quimicos report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
657.17%
Total operating revenue
274.5%
Operating profit (EBIT)
116.43%
EBITDA
129.44%
Net Profit (Loss) for the Period
80.27%
Total Assets
-82.99%
Total Equity
-37.31%
Operating Profit Margin (ROS)
-9.38%
Net Profit Margin
-6.19%
Return on Equity (ROE)
30.24%
Debt/Equity
22.65%
Quick Ratio
0.56%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?